The modern EP practice: EHR and remote monitoring

Cardiology Clinics

Volumn 32, Issue 2, 2014, Pages 239-252

  Mittal, Suneet ^a   Movsowitz, Colin ^b   Varma, Niraj ^c  

^a VALLEY HOSPITAL   (United States)

^b EINSTEIN MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Defibrillators; Follow up; Patient monitoring; Remote monitoring guidelines

Indexed keywords

CARDIAC EQUIPMENT; CARDIAC IMPLANTABLE ELECTRONIC DEVICE; COST BENEFIT ANALYSIS; DEVICE RECALL; DEVICE SAFETY; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PATIENT MONITORING; PRIORITY JOURNAL; REIMBURSEMENT; REMOTE SENSING; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SYSTEM ANALYSIS; WIRELESS COMMUNICATION; AMBULATORY MONITORING; ARRHYTHMIAS, CARDIAC; CLINICAL TRIAL (TOPIC); DEVICE FAILURE; DEVICES; EARLY DIAGNOSIS; ECONOMICS; EQUIPMENT DESIGN; FORECASTING; PATIENT SELECTION; PROCEDURES; TELEMEDICINE;

ARRHYTHMIAS, CARDIAC; CLINICAL TRIALS AS TOPIC; DEFIBRILLATORS, IMPLANTABLE; EARLY DIAGNOSIS; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FORECASTING; HEART FAILURE; HUMANS; MONITORING, AMBULATORY; PATIENT SELECTION; REIMBURSEMENT MECHANISMS; TELEMEDICINE;

EID: 84899703008     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2014.01.001     Document Type: Review

References (41)

1. Marinskis G., van Erven L., Bongiorni M.G., et al. Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey. Europace 2012, 14:423-425.
2. Al-Khatib S.M., Mi X., Wilkoff B.L., et al. Follow-up of patients with new cardiovascular implantable electronic devices: are experts' recommendations implemented in routine clinical practice?. Circ Arrhythm Electrophysiol 2012, 6:108-116.
3. Hess P.L., Mi X., Curtis L.H., et al. Follow-up of patients with new cardiovascular implantable electronic devices: is adherence to the experts' recommendations associated with improved outcomes?. Heart Rhythm 2013, 10:1127-1133.
4. Wilkoff B.L., Auricchio A., Brugada J., et al. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm 2008, 5:907-925.
5. Schoenfeld M.H., Compton S.J., Mead R.H., et al. Remote monitoring of implantable cardioverter defibrillators: a prospective analysis. Pacing Clin Electrophysiol 2004, 27:757-763.
6. Joseph G.K., Wilkoff B.L., Dresing T., et al. Remote interrogation and monitoring of implantable cardioverter defibrillators. JInterv Card Electrophysiol 2004, 11:161-166.
7. Cronin E., Ching E.A., Varma N., et al. Remote monitoring of cardiovascular devices: a time and activity analysis. Heart Rhythm 2012, 9:1947-1951.
8. Al-Khatib S.M., Piccini J.P., Knight D., et al. Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial. JCardiovasc Electrophysiol 2010, 21:545-550.
9. Crossley G.H., Chen J., Choucair W., et al. Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers. JAm Coll Cardiol 2009, 54:2012-2019.
10. de Asmundis C., Ricciardi D., Namdar M., et al. Role of home monitoring in children with implantable cardioverter defibrillators for Brugada syndrome. Europace 2013, 15:i17-i25.
11. Varma N., Stambler B., Chun S. Detection of atrial fibrillation by implanted devices with wireless data transmission capability. Pacing Clin Electrophysiol 2005, 28(Suppl 1):S133-S136.
12. Varma N., Epstein A., Irimpen A., TRUST Investigators, et al. Efficacy and safety of automatic remote monitoring for ICD follow-up: the TRUST trial. Circulation 2010, 122:325-332.
13. Varma N., Michalski J., Epstein A.E., et al. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circ Arrhythm Electrophysiol 2010, 3:428-436.
14. Varma N., Michalski J., Epstein A., TRUST Investigators Long term preservation of battery longevity (despite daily transmission load) with home monitoring-The TRUST trial. Europace 2013, (Suppl). Abstract.
15. Varma N. Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T reduces routine office device follow-up study (TRUST) study. Am Heart J 2007, 154:1029-1034.
16. Guedon-Moreau L., Lacroix D., Sadoul N., et al. Arandomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J 2012, 34:605-614.
17. Mabo P., Victor F., Bazin P., et al. Arandomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). Eur Heart J 2012, 33:1105-1111.
18. Ricci R.P., Morichelli L., D'Onofrio A., et al. Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the HomeGuide registry. Europace 2013, 15(7):970-977. 10.1093/europace/eus440.
19. Crossley G., Boyle A., Vitense H., et al. The Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision (CONNECT) trial: the value of wireless remote monitoring with automatic clinician alerts. JAm Coll Cardiol 2011, 57:1181-1189.
20. Medtronic I. Clinician manual supplement Protecta XT/Protecta projected service life information related to remote monitoring. 2010; Manual no: M945739A001A.
21. Varma N., Pavri B.B., Stambler B., et al. Same-day discovery of implantable cardioverter defibrillator dysfunction in the TRUST remote monitoring trial: influence of contrasting messaging systems. Europace 2013, 15:697-703.
22. Varma N. Automatic remote home monitoring of ICD lead and generator function-a system that tests itself everyday. Europace 2013, 15:i26-i31.
23. Carlson M.D., Wilkoff B.L., Maisel W.H., et al. Recommendations from the Heart Rhythm Society task force on device performance policies and guidelines endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and Electrophysiology organizations (COPE). Heart Rhythm 2006, 3:1250-1273.
24. Maisel W.H., Hauser R.G., Hammill S.C., et al. Recommendations from the Heart Rhythm Society task force on lead performance policies and guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm 2009, 6:869-885.
25. Varma N. Remote monitoring for advisories: automatic early detection of silent lead failure. Pacing Clin Electrophysiol 2009, 32:525-527.
26. Maisel W.H., Sweeney M.O., Stevenson W.G., et al. Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators. JAMA 2001, 286:793-799.
27. Maisel W.H., Stevenson W.G., Epstein L.M. Changing trends in pacemaker and implantable cardioverter defibrillator generator advisories. Pacing Clin Electrophysiol 2002, 25:1670-1678.
28. Medtronic physician advisory letter: urgent medical device information Sprint Fidelis lead patient management recommendations. Available at:. 2007. Accessed February 3, 2014. http://www.medtronic.com/product-advisories/physician/sprint-fidelis/PROD-ADV-PHYS-OCT.htm.
29. Kallinen L.M., Hauser R.G., Lee K.W., et al. Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm 2008, 5:775-779.
30. Burri H. Remote follow-up and continuous remote monitoring, distinguished. Europace 2013, 15:i14-i16.
31. Ricci R.P., Morichelli L., Gargaro A., et al. Home monitoring in patients with implantable cardiac devices: is there a potential reduction of stroke risk? Results from a computer model tested through Monte Carlo simulations. JCardiovasc Electrophysiol 2009, 20:1244-1251.
32. Santini M., Gasparini M., Landolina M., et al. Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. JAm Coll Cardiol 2011, 57:167-172.
33. Koplan B.A., Kaplan A.J., Weiner S., et al. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary?. JAm Coll Cardiol 2009, 53:355-360.
34. Chaudhry S.I., Mattera J.A., Curtis J.P., et al. Telemonitoring in patients with heart failure. NEngl J Med 2010, 363:2301-2309.
35. Varma N., Wilkoff B. Device features for managing patients with heart failure. Heart Fail Clin 2011, 7:215-225.
36. Whellan D.J., Ousdigian K.T., Al-Khatib S.M., et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. JAm Coll Cardiol 2010, 55:1803-1810.
37. Hindricks G. The INTIME trial. Available at:. 2013. ESC Hotline Session. Accessed February 3, 2014. http://www.escardio.org/about/press/esc-congress-2013/press-conferences/Documents/slides/hindricks.pdf.
38. Saxon L.A., Hayes D.L., Gilliam F.R., et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation 2010, 122:2359-2367.
39. Bonnell S., Mittal S. Clinical guidelines for remote monitoring. Remote monitoring and physiologic sensing technologies (Cardiac Electrophysiology Clinics) 2013, 283-292. Elsevier, Philadelphia. S.J. Asirvatham, K.L. Venkatachalam, S. Kapa (Eds.).
40. Varma N., Ricci R.P. Telemedicine and cardiac implants: what is the benefit?. Eur Heart J 2012, 34:1885-1895.
41. Mitchell M. Emerging applications for remote monitoring. EP Lab Digest 2012, 12:30-32.